Thesis (M.S.)--University of Wisconsin--Madison, 1970. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.

Thesis (doctoral)--Freie Universität Berlin, 1979.

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2005. / Härtill 4 uppsatser.

Objetivo: Determinar la relación entre mal control glicémico y bacteriuria asintomática (BA) en pacientes diabéticos tipo 2. Materiales y Métodos: Se llevó a cabo un estudio transversal analítico que incluyó 356 pacientes diabéticos atendidos en el Hospital Nacional Alberto Sabogal Sologuren (HNASS)durante el 2011 y 2012. Las variables bacteriuria asintomática, hemoglobina glicosilada (HbA1c), creatinina sérica, microalbuminuria, tiempo de diagnóstico, índice de masa corporal (IMC), fecha de última menstruación, antecedente de patología prostática e incontinencia urinaria se obtuvieron de las historias clínicas. Resultados: De 356 pacientes con DM2 se encontró presencia de BA en 51,9% de la población estudiada. Se halló asociación entre HbA1c mayor o igual a 6,5% y la presencia de BA (RP= 3,4, IC 95% 2,2 – 5,2). En el análisis multivariado, la variable control metabólico, ajustada por las variables IMC, género y tiempo de diagnóstico de DM2, estuvo asociada con BA (RP= 3,3, IC 95% 2,2 – 5). Conclusiones: Los valores de HbA1c elevados se encuentran asociados a la presencia de bacteriuria asintomática, por lo cual se recomienda mantener niveles inferiores a 6,5%; con la finalidad de reducir el riesgo de BA y su predisposición a infección urinaria y daño renal. . / Objective: To determine the relationship between bad glycemic control and asymptomatic bacteriuria (AB) in type 2 diabetic patients. Materials and Methods: a cross-sectional study, including 356 diabetic patients treated at NationalHospital Alberto Sabogal Sologuren (HNASS) during the years 2011 and 2012. The variables are asymptomatic bacteriuria, Hemoglobin A glycosylated (HbA1c), serum creatinine, microalbuminuria, time to diagnosis, date last menstrual period, history of prostate pathology and urinary incontinence were obtained from medical records. Results: From 356 patients with DM2 was found 51.9% presence of AB in the study population. Association was found between HbA1c greater than or equal to 6.5% and AB (PR= 3.4, CI95% 2.2 – 5.2). In addition, male gender was found between AB and prostatic syndrome (p <0.05). In multivariate analysis, the variable metabolic control adjusted for BMI variables, gender and time of diagnosis of type 2 diabetes mellitus was associated with AB (PR = 3.3, CI 95% 2.2 – 5). Conclusions: elevated HbA1c values were associated with the presence of AB, so we recommend keeping HbA1c levels <6.5% because AB may predispose the patient to urinary tract infection and possible kidney damage.

Objective: The aims of this prospective clinical cohort study were to determine the prevalence of asymptomatic bacteriuria in dogs with cranial cruciate ligament disease and to determine which clinical parameters and clinicopathologic data are associated with asymptomatic bacteriuria. Another aim was to determine the incidence of surgical site infections in dogs with and without asymptomatic bacteriuria. Results: In 156 dogs with cruciate ligament disease, the prevalence of asymptomatic bacteriuria was 7.1%. Furthermore, the prevalence was 12.4% in female dogs and 0% in male dogs. The most common bacterial isolate was Escherichia coli. Patient sex, urine white blood cells/ high-powered field, and microscopic bacteriuria were significantly different between dogs with and without asymptomatic bacteriuria. Only 60% of dogs with microscopic bacteriuria had growth on urine aerobic culture. No significant difference was found in age, body weight, body condition score, duration of lameness, limb affected, or other urinalysis values between dogs with and without asymptomatic bacteriuria. Of the dogs that had 8-week repeat cultures, 2/3 dogs with asymptomatic bacteriuria had negative urine cultures and 3/43 without asymptomatic bacteriuria had positive urine cultures. Of 57 dogs that received surgery and had sufficient follow-up, 15 developed surgical site infection. All surgical site infections occurred in dogs without AB. The incidence of surgical site infection in this population was 26.3% (15/57). Conclusions: Prevalence of asymptomatic bacteriuria in dogs presenting with cranial cruciate ligament disease was similar to previously reported values in male and female dogs. This suggests that dogs with cranial cruciate ligament disease are not more prone to asymptomatic bacteriuria than dogs in previously studied populations. Preliminary data suggests that AB does not predispose dogs to SSI however further research and continued data collection is warranted. / Master of Science / Asymptomatic bacteriuria is defined as having bacteria in the urine without signs of lower urinary tract disease. The aim of this study was to determine the prevalence asymptomatic bacteriuria in dogs with cranial cruciate ligament disease. Additionally, another aim was to determine the incidence of surgical site infections after cranial cruciate ligament surgery in dogs with and without asymptomatic bacteriuria. Prevalence of asymptomatic bacteriuria in dogs presenting with cranial cruciate ligament disease was found to be similar to previously reported values in male and female dogs. This suggests that dogs with cranial cruciate ligament disease are not more prone to asymptomatic bacteriuria than dogs in previously studied populations. Preliminary data suggests that dogs with bacteria in the urine does not predispose dogs to SSI however further research and continued data collection is warranted.

INTRODUÇÃO: As infecções do trato urinário (ITU) feminino são muito prevalentes em mulheres. Em geral, elas dividem-se em cistites e pielonefrites de acordo com seu nível anatômico. Seu tratamento, apesar de simples, depende do conhecimento da flora bacteriana e do padrão de sensibilidade local, principalmente em tempos de aumento de resistência bacteriana. Este estudo avaliou e comparou a flora e o padrão de sensibilidade das bactérias causadoras de infecção não complicada do trato urinário feminino no período de 2007 a 2012. MÉTODOS: Analisamos retrospectivamente os resultados de 493 culturas de urina de pacientes com idade a partir de 14 anos e sintomas clínicos de cistite ou pielonefrite tratadas no Pronto-Socorro ou Ambulatório de Urologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. As pacientes foram separadas em três grupos: 1- pacientes com cistite simples atendidas no Pronto-Socorro; 2- pacientes com cistite simples atendidas no Ambulatório; 3- pacientes com pielonefrite atendidas no Pronto-Socorro. As características demográficas como idade, presença de ITU de repetição, diabetes mellitus (DM) e outras comorbidades, e os resultados de flora bacteriana e padrão de sensibilidade foram analisados e comparados entre os grupos. RESULTADOS: A média de idade das pacientes nos três grupos foi 43,2, 55,0 e 36,0 anos, respectivamente. ITU de repetição esteve presente em 36,0%, 76,1% e 26,5% das pacientes dos grupos 1, 2 e 3, respectivamente, enquanto que 8,5%, 22,7% e 2,2% das pacientes nos grupos 1, 2 e 3, respectivamente, eram diabéticas. Escherichia coli (E. coli) foi a bactéria responsável por 75,1% das infecções no geral e 87,3% das pielonefrites. Staphylococcus saprophyticus foi o segundo agente etiológico mais frequente (6,7%), principalmente no grupo 1 (10,0%), enquanto que nas diabéticas, Enterococcus faecalis foi o segundo agente etiológico (15,6%). Ao avaliarmos todas as pacientes, o antibiograma demonstrou sensibilidade à amoxacilina/ácido clavulânico (AAC), ampicilina, ciprofloxacina, levofloxacina, nitrofurantoína, norfloxacina e sulfametoxazol/trimetoprima (SMT) de 85,8%, 46,5%, 82,0%, 83,3%, 88,3%, 83,3% e 65,7%, respectivamente. Nas pielonefrites, a sensibilidade geral à cefalotina, cefepime, ceftriaxone, ciprofloxacina e gentamicina foi de 67,0%, 95,5%, 94,3%, 81,8% e 98,0%, respectivamente. Ao analisarmos apenas as infecções por E. coli, os antibióticos orais com sensibilidade > 90% foram AAC (96,5%) e nitrofurantoína (98,8%). No geral, ao compararmos pacientes sem e com ITU de repetição, os antibióticos amicacina, gentamicina e nitrofurantoína foram os únicos que não apresentaram diminuição significativa de sensibilidade. Nas infecções de repetição por E. coli, os únicos antibióticos orais que mantiveram sensibilidade > 90% foram AAC e nitrofurantoína. Ao compararmos ITU por E. coli nas pacientes = 50 anos, os antimicrobianos orais que mantiveram sensibilidade > 90% em ambas faixas etárias foram AAC e nitrofurantoína. Nas pacientes diabéticas, houve diminuição estatística da sensibilidade ao ácido nalidíxico (80,5% x 61,5%), ciprofloxacina (84,8% x 65,1%), gentamicina (97,4% x 81,0%), levofloxacina (85,4% x 66,7%) e SMT (66,0% x 50%), respectivamente. As infecções por E. coli nas pacientes diabéticas também apresentaram diminuição estatística aos mesmos antibióticos; AAC e nitrofurantoína mantiveram sensibilidade > 95% nesta situação. Análise de regressão logística identificou aumento de chance de resistência ao ácido nalidíxico, ciprofloxacina e levofloxacina de 3,62, 4,72 e 5,27, respectivamente, quando há ITU de repetição, e à gentamicina de 5,38 quando há DM. CONCLUSÕES: Pielonefrites foram mais comuns em mulheres jovens em relação às cistites. E. coli foi o principal agente causador das infecções urinárias não complicadas, principalmente em pielonefrites. A nitrofurantoína manteve sensibilidade in vitro acima de 90% em diversas situações como no tratamento geral das cistites por E. coli, em casos de cistite de repetição, em mulheres > 50 anos e em diabéticas. AAC mostrou sensibilidade in vitro acima de 90% em algumas situações: ITU de repetição por E. coli, mulheres com idade >= 50 anos e diabéticas. A ceftriaxone apresentou sensibilidade in vitro suficiente para o tratamento empírico de pielonefrite. O histórico de infecção urinária de repetição aumentou a chance de resistência ao ácido nalidíxico, ciprofloxacina e levofloxacina e DM aumentou a chance de resistência à gentamicina. / INTRODUCTION: Uncomplicated urinary tract infections (UTIs) in women are common. Urinary tract infections are usually divided into cystitis or pyelonephritis, according to anatomical level. Although treatment of UTI is simple, it depends on knowledge of the local uropathogens and antimicrobial susceptibility patterns due to increasing antimicrobial resistance. This study analyzed the causative pathogens of UTIs in women and their susceptibility patterns between 2007 and 2012. METHODS: We conducted a retrospective analysis of 493 urine culture results of female patients aged 14 years and older with clinical diagnosis of cystitis or pyelonephritis who were treated at the urological emergency unit or urological outpatient clinic. Patients were divided into three groups: 1- simple cystitis attended to in the emergency unit; 2- simple cystitis attended to in the urological outpatient clinic; 3- pyelonephritis attended to in the emergency unit. Results of demographic data, such as age, history of recurrent UTI, diabetes mellitus (DM) and comorbidities, and those of the causative pathogens and their susceptibility patterns were analyzed and compared. RESULTS: The mean age for groups 1, 2 and 3 was 43.2, 55.0 and 36.0 years, respectively. Recurrent UTI was present in 36.0%, 76.1% and 26.5% of patients in groups 1, 2 and 3, respectively. DM was present in 8.5%, 22.7% and 2.2% of patients in group 1, 2 and 3, respectively. Escherichia coli (E. coli) was responsible for 75.1% of all UTIs and 87.3% of pyelonephritis. Staphylococcus saprophyticus was the second most common agent (6.7%), mainly in group 1 (10.0%), while Enterococcus faecalis was the second most common agent in diabetic patients (15.6%). General susceptibility rates to amoxicillin/clavulanate (A/C), ampicillin, ciprofloxacin, levofloxacin, nitrofurantoin, norfloxacin and sulfamethoxazole/trimethoprim (SMT) were 85.8%, 46.5%, 82.0%, 83.3%, 88.3%, 83.3% and 65.7%, respectively. For pyelonephritis, the general susceptibility rates to cephalothin, cefepime, ceftriaxone, ciprofloxacin and gentamicin were 67.0%, 95.5%, 94.3%, 81.8% and 98.0%, respectively. Analysis of the E.coli isolates showed that more than 90% of the strains were susceptible to A/C (96.5%) and nitrofurantoin (98.8%). There was a decrease in the susceptibility rates to all antimicrobials in patients with recurrent UTI, except for amikacin, gentamicin and nitrofurantoin. In cases of recurrent UTI by E. coli, susceptibility rates for oral nitrofurantoin and A/C were above 90%. In a comparison of patients below 50 years and those aged 50 and older diagnosed with E. coli UTI, only A/C and nitrofurantoin maintained susceptibility rates above 95% for all ages. Comparison between diabetic and non-diabetic patients showed a significant decrease in susceptibility rates for ciprofloxacin (84.8% x 65.1%), gentamicin (97.4% x 81.0%), levofloxacin (85.4% x 66.7%), nalidixic acid (80.5% x 61.5%) and SMT (66.0% x 50%), respectively. A similar susceptibility rate of E. coli was found in diabetic patients; however, A/C and nitrofurantoin maintained susceptibility rates above 95% in this situation. A multivariate analysis identified an increased odds of resistance to ciprofloxacin, levofloxacin and nalidixic acid (OR=4.72, 5.27 and 3.62, respectively) in the presence of recurrent UTI, while there was an increased probability for resistance to gentamicin (OR=5.38) in the presence of DM. CONCLUSIONS: Pyelonephritis was more common in young women than cystitis. E. coli was the main agent for uncomplicated UTI, particularly for pyelonephritis. Nitrofurantoin maintained in vitro susceptibility rates above 90% in many situations, such as E. coli infections, recurrent infections, women older than 50 years and diabetic patients. A/C maintained susceptibility rates above 90 % in some situations, such as recurring UTI caused by E. coli, women aged 50 years or older and diabetic patients. Ceftriaxone had a sufficient in vitro susceptibility profile to be indicated for empirical treatment of pyelonephritis. Recurrent UTI increased the odds of resistance to ciprofloxacin, levofloxacin and nalidixic acid, while DM increased the chance of resistance to gentamicin

INTRODUÇÃO: As infecções do trato urinário (ITU) feminino são muito prevalentes em mulheres. Em geral, elas dividem-se em cistites e pielonefrites de acordo com seu nível anatômico. Seu tratamento, apesar de simples, depende do conhecimento da flora bacteriana e do padrão de sensibilidade local, principalmente em tempos de aumento de resistência bacteriana. Este estudo avaliou e comparou a flora e o padrão de sensibilidade das bactérias causadoras de infecção não complicada do trato urinário feminino no período de 2007 a 2012. MÉTODOS: Analisamos retrospectivamente os resultados de 493 culturas de urina de pacientes com idade a partir de 14 anos e sintomas clínicos de cistite ou pielonefrite tratadas no Pronto-Socorro ou Ambulatório de Urologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. As pacientes foram separadas em três grupos: 1- pacientes com cistite simples atendidas no Pronto-Socorro; 2- pacientes com cistite simples atendidas no Ambulatório; 3- pacientes com pielonefrite atendidas no Pronto-Socorro. As características demográficas como idade, presença de ITU de repetição, diabetes mellitus (DM) e outras comorbidades, e os resultados de flora bacteriana e padrão de sensibilidade foram analisados e comparados entre os grupos. RESULTADOS: A média de idade das pacientes nos três grupos foi 43,2, 55,0 e 36,0 anos, respectivamente. ITU de repetição esteve presente em 36,0%, 76,1% e 26,5% das pacientes dos grupos 1, 2 e 3, respectivamente, enquanto que 8,5%, 22,7% e 2,2% das pacientes nos grupos 1, 2 e 3, respectivamente, eram diabéticas. Escherichia coli (E. coli) foi a bactéria responsável por 75,1% das infecções no geral e 87,3% das pielonefrites. Staphylococcus saprophyticus foi o segundo agente etiológico mais frequente (6,7%), principalmente no grupo 1 (10,0%), enquanto que nas diabéticas, Enterococcus faecalis foi o segundo agente etiológico (15,6%). Ao avaliarmos todas as pacientes, o antibiograma demonstrou sensibilidade à amoxacilina/ácido clavulânico (AAC), ampicilina, ciprofloxacina, levofloxacina, nitrofurantoína, norfloxacina e sulfametoxazol/trimetoprima (SMT) de 85,8%, 46,5%, 82,0%, 83,3%, 88,3%, 83,3% e 65,7%, respectivamente. Nas pielonefrites, a sensibilidade geral à cefalotina, cefepime, ceftriaxone, ciprofloxacina e gentamicina foi de 67,0%, 95,5%, 94,3%, 81,8% e 98,0%, respectivamente. Ao analisarmos apenas as infecções por E. coli, os antibióticos orais com sensibilidade > 90% foram AAC (96,5%) e nitrofurantoína (98,8%). No geral, ao compararmos pacientes sem e com ITU de repetição, os antibióticos amicacina, gentamicina e nitrofurantoína foram os únicos que não apresentaram diminuição significativa de sensibilidade. Nas infecções de repetição por E. coli, os únicos antibióticos orais que mantiveram sensibilidade > 90% foram AAC e nitrofurantoína. Ao compararmos ITU por E. coli nas pacientes = 50 anos, os antimicrobianos orais que mantiveram sensibilidade > 90% em ambas faixas etárias foram AAC e nitrofurantoína. Nas pacientes diabéticas, houve diminuição estatística da sensibilidade ao ácido nalidíxico (80,5% x 61,5%), ciprofloxacina (84,8% x 65,1%), gentamicina (97,4% x 81,0%), levofloxacina (85,4% x 66,7%) e SMT (66,0% x 50%), respectivamente. As infecções por E. coli nas pacientes diabéticas também apresentaram diminuição estatística aos mesmos antibióticos; AAC e nitrofurantoína mantiveram sensibilidade > 95% nesta situação. Análise de regressão logística identificou aumento de chance de resistência ao ácido nalidíxico, ciprofloxacina e levofloxacina de 3,62, 4,72 e 5,27, respectivamente, quando há ITU de repetição, e à gentamicina de 5,38 quando há DM. CONCLUSÕES: Pielonefrites foram mais comuns em mulheres jovens em relação às cistites. E. coli foi o principal agente causador das infecções urinárias não complicadas, principalmente em pielonefrites. A nitrofurantoína manteve sensibilidade in vitro acima de 90% em diversas situações como no tratamento geral das cistites por E. coli, em casos de cistite de repetição, em mulheres > 50 anos e em diabéticas. AAC mostrou sensibilidade in vitro acima de 90% em algumas situações: ITU de repetição por E. coli, mulheres com idade >= 50 anos e diabéticas. A ceftriaxone apresentou sensibilidade in vitro suficiente para o tratamento empírico de pielonefrite. O histórico de infecção urinária de repetição aumentou a chance de resistência ao ácido nalidíxico, ciprofloxacina e levofloxacina e DM aumentou a chance de resistência à gentamicina. / INTRODUCTION: Uncomplicated urinary tract infections (UTIs) in women are common. Urinary tract infections are usually divided into cystitis or pyelonephritis, according to anatomical level. Although treatment of UTI is simple, it depends on knowledge of the local uropathogens and antimicrobial susceptibility patterns due to increasing antimicrobial resistance. This study analyzed the causative pathogens of UTIs in women and their susceptibility patterns between 2007 and 2012. METHODS: We conducted a retrospective analysis of 493 urine culture results of female patients aged 14 years and older with clinical diagnosis of cystitis or pyelonephritis who were treated at the urological emergency unit or urological outpatient clinic. Patients were divided into three groups: 1- simple cystitis attended to in the emergency unit; 2- simple cystitis attended to in the urological outpatient clinic; 3- pyelonephritis attended to in the emergency unit. Results of demographic data, such as age, history of recurrent UTI, diabetes mellitus (DM) and comorbidities, and those of the causative pathogens and their susceptibility patterns were analyzed and compared. RESULTS: The mean age for groups 1, 2 and 3 was 43.2, 55.0 and 36.0 years, respectively. Recurrent UTI was present in 36.0%, 76.1% and 26.5% of patients in groups 1, 2 and 3, respectively. DM was present in 8.5%, 22.7% and 2.2% of patients in group 1, 2 and 3, respectively. Escherichia coli (E. coli) was responsible for 75.1% of all UTIs and 87.3% of pyelonephritis. Staphylococcus saprophyticus was the second most common agent (6.7%), mainly in group 1 (10.0%), while Enterococcus faecalis was the second most common agent in diabetic patients (15.6%). General susceptibility rates to amoxicillin/clavulanate (A/C), ampicillin, ciprofloxacin, levofloxacin, nitrofurantoin, norfloxacin and sulfamethoxazole/trimethoprim (SMT) were 85.8%, 46.5%, 82.0%, 83.3%, 88.3%, 83.3% and 65.7%, respectively. For pyelonephritis, the general susceptibility rates to cephalothin, cefepime, ceftriaxone, ciprofloxacin and gentamicin were 67.0%, 95.5%, 94.3%, 81.8% and 98.0%, respectively. Analysis of the E.coli isolates showed that more than 90% of the strains were susceptible to A/C (96.5%) and nitrofurantoin (98.8%). There was a decrease in the susceptibility rates to all antimicrobials in patients with recurrent UTI, except for amikacin, gentamicin and nitrofurantoin. In cases of recurrent UTI by E. coli, susceptibility rates for oral nitrofurantoin and A/C were above 90%. In a comparison of patients below 50 years and those aged 50 and older diagnosed with E. coli UTI, only A/C and nitrofurantoin maintained susceptibility rates above 95% for all ages. Comparison between diabetic and non-diabetic patients showed a significant decrease in susceptibility rates for ciprofloxacin (84.8% x 65.1%), gentamicin (97.4% x 81.0%), levofloxacin (85.4% x 66.7%), nalidixic acid (80.5% x 61.5%) and SMT (66.0% x 50%), respectively. A similar susceptibility rate of E. coli was found in diabetic patients; however, A/C and nitrofurantoin maintained susceptibility rates above 95% in this situation. A multivariate analysis identified an increased odds of resistance to ciprofloxacin, levofloxacin and nalidixic acid (OR=4.72, 5.27 and 3.62, respectively) in the presence of recurrent UTI, while there was an increased probability for resistance to gentamicin (OR=5.38) in the presence of DM. CONCLUSIONS: Pyelonephritis was more common in young women than cystitis. E. coli was the main agent for uncomplicated UTI, particularly for pyelonephritis. Nitrofurantoin maintained in vitro susceptibility rates above 90% in many situations, such as E. coli infections, recurrent infections, women older than 50 years and diabetic patients. A/C maintained susceptibility rates above 90 % in some situations, such as recurring UTI caused by E. coli, women aged 50 years or older and diabetic patients. Ceftriaxone had a sufficient in vitro susceptibility profile to be indicated for empirical treatment of pyelonephritis. Recurrent UTI increased the odds of resistance to ciprofloxacin, levofloxacin and nalidixic acid, while DM increased the chance of resistance to gentamicin

The epidemiology of urinary tract infection (UTI) in the population of Vännäs (8 000 inhabitants) was studied during one year. The annual incidence increased from 0.5% in the first decade of life to more than 10% in the age group 90-100 years. Male UTI comprised only 13% of the episodes, increased after middle age and contributed 4 0% by &gt; 80 years of age. At 17 PHC centres (PHCCs) a prevalence study (McPHC) of mainly uncomplicated UTI was performed. Most episodes were acutely symptomatic (lower 75%, upper 5%). Microscopy of wet-stained urinary sediment with a minimum of moderate amount of bacteria and/or 5 leukocytes per high power field (4 00 x) as breakpoint resulted in a desired high sensitivity (97%) and 86% efficacy in acutely symptomatic patients. Diagnosis of bacteriuria using Uricult dipslides yielded acceptable results with an overall efficacy of 88%. Nitrite test and Uriglox showed an unacceptable low mean sensitivity ofR56 and 69%, respectively. A positive nitrite, sediment or Uricult , when used in combination, was optimal in diagnosing UTI with a sensitivity of 98% in acutely symptomatic patients during their office visits. The average risk of drug resistance was 17% in the Vännäs study. Sensicult satisfactorily predicted drug sensitivity (93%) but not bacterial drug resistance (50%). Using Uricult with classification of bacteriuria by Gram-grouping, lactose and catalase reactions for targeting UTI therapy, according to local guidelines, resulted in a similar low risk (6 %) of prescribing drugs to which the organisms were resistagt as when using Sensicult (7%). This development of the Uricult method is simple and can be recommended for office practice in PHC. The spectrum of bacteria causing UTI and their drug resistance was more associated with the selection of patients, sex and age than with symptoms. The pattern of drug resistance was little influenced by UTI history and the mean pretherapy resistance for the seven drugs tested in McPHC was low (7%). Drug resistance was increased in failure (mean 24%) but not in early or repeated recurrence. In McPHC therapy resulted in 8% bacteriological failure and 12% early recurrence, irrespective of whether the bacteria were classified as sensitive or resistant in vitro to the drug given. Thus, in order to be of prognostic value for therapy of uncomplicated UTI, high-level breakpoints focusing more on peak urinary drug concentrations need to be studied. UTI symptoms in McPHC were eradicated in only 2/3 of the bacterio- logically cured episodes and in 1/3 of the failures at control 1-3 days posttherapy showing that symptoms are an unreliable indicator of UTI. From current literature, it seems unlikely that asymptomatic bacteriuria (ABU) plays a major role in the development of uremia due to chronic pyelonephritis. With the exception of ABU in pregnancy, therapy seems to yield no benefit. Omitting posttherapy bacteriuria controls in patients with symptoms eradicated, at least in women with uncomplicated UTI, would lead to considerable savings both for patients and the health care system. / <p>Diss. (sammanfattning) Umeå : Umeå universitet, 1988, härtill 6 uppsatser.</p> / digitalisering@umu

The aim of this thesis was to explore the features of asymptomatic bacteriuria (ASB) in elderly people living in the community, and to seek diagnostic tools to discriminate between ASB and symptomatic urinary tract infection (UTI). All men and women aged 80 and over living in an urban district of Falun, Sweden, were invited to participate. Urine samples were obtained together with information on symptoms and on health indicators. The same cohort was surveyed again after 6 and 18 months. Urinary cytokines were analysed in 16 patients with UTI, in 24 subjects with ASB and in 20 negative controls. ASB occurred at baseline in 19.0% of women and 9.4% of men, and was found at least once in 36.9% of women and in 20.2% of men. ASB in women was associated with reduced mobility and urge urinary incontinence. Of those with ASB at baseline, 60% still had bacteriuria at 6 and 18 months, but among those with repeated findings of ASB with E. coli, only 40% had the same bacterial strain after 18 months. In women, the risk of developing a UTI within 24 months was higher among those with ASB at baseline than in those without. Urinary levels of cytokines (CXCL1, CXCL8 and IL-6) and leukocyte esterase were higher in patients with UTI than in patients with ASB. There is convincing evidence that ASB is harmless and should not be treated with antibiotics. However, such treatment is still often given, thereby unnecessarily contributing to the increased number of bacteria resistant to common antibiotics. This study confirms the high prevalence of ASB in elderly people living in the community. In order not to be misled by a urinary test showing bacteria, it is important to restrict urinary testing for bacteria to patients where there is a suspicion of UTI. In elderly patients with diffuse symptoms or in patients who are unable to communicate their symptoms, further diagnostic help could possibly be obtained by evaluating the urinary levels of leukocyte esterase and/or IL-6.

Urinvägsinfektioner (UVI) är ett vanligt hälsoproblem som drabbar miljontals människor. Den allvarligaste formen, akut pyelonefrit (APN) kan ge svåra komplikationer. Urinvägspatogena Escherichia coli (UPEC) som orsakar APN uttrycker P fimbrier som specifikt binder till glykosphingolipider på ytan av uroepitelceller. Det sätter igång en toll-like receptor 4 (TLR4) beroende men LPS-oberoende immunreaktion. Den roll som interferon beta (IFN-β) spelar vid bakterieinfektioner är inte helt klarlagd men studier som gjorts på IFN-β knockoutmöss visade på en ökad infektionsbenägenhet och svåra njursymptom vid infektion med UPEC. IFN-β uttrycket i uroepitelceller som svar på bakterieinfektion undersöktes. För att ta reda på om uttrycket är P fimbrieberoende infekterades humana A498 njurcarcinomceller med den P fimbrieförsedda pyelonefritstammen CFT073 eller den icke-virulenta asymtomatisk bakterieuristammen E. coli 83972 och inkuberades i 1,5 respektive 4 timmar. Som kontroll användes celler som enbart behandlats med PBS. Uttrycket av IFN-β analyserades med immunofluorescens (IF) och konfokalmikroskopi, samt med Western blot. Resultaten från konfokalmikroskopi visade att celler som exponerats för CFT073 under 4 timmar uttryckte mest IFN-β medan cellerna som utsatts för E. coli 83972 visade på ett omvänt förhållande. Western blot visade på högst uttryck i de E. coli 83972-behandlade cellerna. IFN-β uttrycktes i alla celler, inklusive kontrollcellerna, i någon utsträckning. Det kan betyda att IFN-β även induceras på någon alternativ väg och/eller att det uttrycks konstitutivt av njurepitelceller. / Urinary tract infections (UTI) are a common health concern and affect millions of people. The most severe form of UTI, acute pyelonephritis (APN) is associated with serious complications. Uropathogenic Escherichia coli (UPEC) that cause APN express P fimbriae which specifically bind to glycosphingolipid molecules on the surface of urothelial cells. This triggers a toll-like receptor 4 (TLR4) mediated but LPS-independent innate immune response. The role of interferon beta (IFN-β) in bacterial infections is not well known but experiments with IFN-β knockout mice have shown an increased susceptibility and severe kidney pathology when infected with UPEC. IFN-β induction in urothelial cells in response to bacterial infection was investigated. To find out whether this response is P fimbriae dependent, A498 human kidney carcinoma epithelial cells were exposed to the P fimbriated CFT073 pyelonephritis strain or the non-virulent E. coli 83972 asymptomatic bacteriuria strain and incubated for 1.5 and 4 hours. For control, cells were treated with PBS alone. The IFN-β expression was analysed using immunofluorescence (IF) and confocal microscopy, and Western blot. Confocal microscopy results showed that the response to bacteria was both time- and dose-dependent. The highest IFN-β expression was detected in cells exposed to CFT073 for 4 hours, while cells exposed to E. coli 83972 showed an inverse relationship. Western blot analysis revealed that the highest expression was in the E. coli 83972 stimulated cells. IFN-β was expressed in all cells to some degree, including control cells. This could imply that IFN-β is induced by some other means and/or is constitutively expressed by kidney epithelial cells.